Home > Portfolio
 
Active Portfolio

Bicycle Therapeutics Ltd.
Cambridge, UK

Cleave Biosciences, Inc.
Burlingame, CA, USA

Crescendo Biologics Ltd.
Cambridge, UK

DecImmune Therapeutics, Inc.
Boston, MA, USA

eFFECTOR Therapeutics, Inc.
San Diego, CA, USA

Innocrin Pharmaceuticals Inc.
Durham, NC, USA

Oncorus, Inc.
Cambridge, MA, USA

PhaseBio Pharmaceuticals, Inc.
Malvern, PA, USA

Raze Therapeutics, Inc.
Cambridge, MA, USA

Tacurion Pharma, Inc.
Bridgewater, NJ, USA

Tizona Therapeutics, Inc.
South San Francisco, CA

Twentyeight-Seven, Inc.
Cambridge, MA, USA

Viamet Pharmaceuticals, Inc.
Durham, NC, USA

Alba Therapeutics
Corporation
Baltimore, MD, USA

Aravive Biologics, Inc.
Palo Alto, CA, USA

CoMentis, Inc.
South San Francisco, CA, USA

F2G Ltd.
Manchester, UK

PanOptica, Inc.
Bernardsville, NJ , USA

Pappas Ventures
Durham, NC, USA


Active Partners

Kanyos Bio, Inc.
Cambridge, MA, USA

Mitobridge, Inc.
Cambridge, MA, USA

Potenza Therapeutics, Inc.
Cambridge, MA, USA

Proteostasis Therapeutics, Inc.
Cambridge, MA, USA


Portfolio Exits

Adherex Technologies Inc.
Ottawa, Canada

AkaRx, Inc.
Paramus, NJ, USA

Cellzome AG
Heidelberg, Germany

Ception Therapeutics, Inc.
Rockville, MD, USA

EPIX Pharmaceuticals, Inc.
Cambridge, MA, USA

EpiZyme, Inc.
Cambridge, MA, USA

Evolva SA
Allschwill, Switzerland

Fate Therapeutics, Inc.
San Diego, CA, USA

HBM Healthcare Investments AG Zug, Switzerland

Intradigm Corporation
Palo Alto, CA, USA

Memory Pharmaceuticals
Corporation
Montvale, NJ, USA

Plexxikon, Inc.
Berkely, CA, USA

TaiGen Biotechnology Co., Ltd.
Taipei, Taiwan R.O.C.

Verastem, Inc.
Cambridge, MA, USA

 
Copyright © 2005 - 2016 Astellas Venture Management. Site Map   Privacy Policy   Legal Disclaimer   Contact Us